COVINA, CA--(MARKET WIRE)--Jun 13, 2007 -- Healtheuniverse Inc. (Other OTC:HLUN.PK - News), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells announced today that patented intellectual property developed by Healtheuniverse may lead to the development of various cell lines that will be utilized to cultivate cells amalgamate to form functional human tissue. These unique cell lines offer an alternative to human embryonic stem cells for medical treatments.
